Follow
David J. Lauffer
David J. Lauffer
Chemistry Research Fellow, Enko Inc.
Verified email at enkochem.com
Title
Cited by
Cited by
Year
Inhibitors of interleukin-1β converting enzyme
GW Bemis, JMC Golec, DJ Lauffer, MD Mullican, MA Murcko, ...
US Patent 5,847,135, 1998
226*1998
Azo amino acids derivatives
D Lauffer, M Mullican
US Patent 6,528,533, 2003
185*2003
Inhibitors of interleukin-1β converting enzyme
GW Bemis, JMC Golec, DJ Lauffer, MD Mullican, MA Murcko
US Patent 5,756,466, 1998
1331998
Inhibitors of interleukin-1β converting enzyme
MJ Batchelor, D Bebbington, GW Bemis, WH Fridman, RJ Gillespie, ...
US Patent 5,874,424, 1999
1141999
Inhibitors of interleukin-1β converting enzyme
JMC Golec, DJ Lauffer, DJ Livingston, MD Mullican, PL Nyce, ...
US Patent 6,350,741, 2002
962002
Compositions useful as inhibitors of GSK-3
J Cao, D Choquette, R Davies, C Forster, D Lauffer, A Pierce, ...
US Patent App. 10/125,885, 2003
932003
Compositions useful as inhibitors of protein kinases
A Aronov, DJ Lauffer, P Li, RC Tomlinson
US Patent 7,446,199, 2008
762008
3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3β
M Arnost, A Pierce, E ter Haar, D Lauffer, J Madden, K Tanner, J Green
Bioorganic & medicinal chemistry letters 20 (5), 1661-1664, 2010
742010
Inhibitors of interleukin-1β converting enzyme
GW Bemis, JMC Golec, DJ Lauffer, MD Mullican, MA Murcko, ...
US Patent 5,973,111, 1999
711999
Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liability
AL Grillot, AL Tiran, D Shannon, E Krueger, Y Liao, H O’Dowd, Q Tang, ...
Journal of Medicinal Chemistry 57 (21), 8792-8816, 2014
702014
c-MET protein kinase inhibitors
DJ Lauffer, RJ Davies, D Stamos, A Aronov, DD Deininger, R Grey Jr, ...
US Patent 7,872,031, 2011
702011
A practical synthesis of (S) 3-tert-butoxycarbonylamino-2-oxo-2, 3, 4, 5-tetrahydro-1, 5-benzodiazepine-1-acetic acid methyl ester as a conformationally restricted dipeptido …
DJ Lauffer, MD Mullican
Bioorganic & medicinal chemistry letters 12 (8), 1225-1227, 2002
642002
Azaindoles useful as inhibitors of JAK and other protein kinases
F Salituro, L Farmer, R Bethiel, E Harrington, J Green, J Come, D Lauffer, ...
US Patent 7,507,826, 2009
572009
Inhibitors of interleukin-1β converting enzyme
GW Bemis, JMC Golec, DJ Lauffer, MD Mullican, MA Murcko, ...
US Patent 6,420,522, 2002
562002
The synthesis and evaluation of peptidyl aspartyl aldehydes as inhibitors of ice.
MD Mullican, DJ Lauffer, RJ Gillespie, SS Matharu, D Kay, GM Porritt, ...
Bioorganic & Medicinal Chemistry Letters 4 (19), 2359-2364, 1994
521994
Dna-pk inhibitors
PS Charifson, KM Cottrell, H Deng, JP Duffy, H Gao, S Giroux, J Green, ...
US Patent 9,376,448, 2016
482016
Pyrrolo [2, 3-D] pyrimidines as inhibitors of Janus kinases
F Salituro, L Farmer, T Wang, J Wang, R Bethiel, M Wannamaker, ...
US Patent 8,580,802, 2013
462013
Inhibitors of interleukin-1β converting enzyme
GW Bemis, JMC Golec, DJ Lauffer, MD Mullican, MA Murcko, ...
US Patent 7,288,624, 2007
432007
Design and Synthesis of m1-​Selective Muscarinic Agonists: (R)​-​(-​)​-​(Z)​-​1-​Azabicyclo[2.2.1]​heptan-​3-​one, O-​(3-​(3'-​Methoxyphenyl)​-​2-​propynyl)​- oxime Maleate (CI …
H Tecle, SD Barrett, DJ Lauffer, C Augelli-Szafran, MR Brann, ...
Journal of Medicinal Chemistry 41 (14), 2524-2536, 1998
401998
Inhibitors of interleukin-1 β converting enzyme
GW Bemis, JMC Golec, DJ Lauffer, MD Mullican, MA Murcko
US Patent 6,025,147, 2000
372000
The system can't perform the operation now. Try again later.
Articles 1–20